What is NDC 70771-1076?

70771-1076 is the product NDC for Cyproheptadine Hydrochloride, Cyproheptadine hydrochloride 4 mg/1 tablet, listed with the FDA by Zydus Lifesciences Limited. It has 2 package NDCs, shown above in 10- and 11-digit form.

Zydus Lifesciences Limited, NDC labeler code 70771. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Cyproheptadine Hydrochloride?

34 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Cyproheptadine Hydrochloride NDC 70771-1076

NDC codes

FDA NDC Directory

Product NDC (as listed)70771-1076Labeler and product segments. Claims need a package NDC.

Product NDC at billing width70771-1076Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
70771-1076-0	7077110760070771107600	1000 TABLET in 1 BOTTLE (70771-1076-0)Marketed from Jul 20, 2017
70771-1076-1	7077110760170771107601	100 TABLET in 1 BOTTLE (70771-1076-1)Marketed from Jul 20, 2017

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Cyproheptadine Hydrochloride
Generic name (nonproprietary): cyproheptadine hydrochloride
Active ingredients: Cyproheptadine hydrochloride — 4 mg/1
Dosage form: Tablet
Route: Oral
Labeler: Zydus Lifesciences LimitedNDC labeler code 70771
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 208938
Marketing start: Jul 20, 2017
Listing expires: Dec 31, 2027
Identifiers: Product ID 70771-1076_465671c3-1e82-41d6-8ce4-b524d0032b15SPL ID 465671c3-1e82-41d6-8ce4-b524d0032b15SPL set ID ccd7d3b2-b0c1-4f66-8d06-d21f5cfa8c1eRxCUI 866144UNII NJ82J0F8QC

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N470771107600 followed by a unit qualifier and the quantity

Package 70771-1076-00. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Nov 26, 2024.

Full label on DailyMed (opens in a new tab)

About NDC 70771-1076

What is NDC 70771-1076?: 70771-1076 is the product NDC for Cyproheptadine Hydrochloride, Cyproheptadine hydrochloride 4 mg/1 tablet, listed with the FDA by Zydus Lifesciences Limited. It has 2 package NDCs, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Cyproheptadine Hydrochloride.
What is the active ingredient?: Cyproheptadine hydrochloride.
Who is the labeler?: Zydus Lifesciences Limited, NDC labeler code 70771. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Cyproheptadine Hydrochloride?: 34 other product NDCs are listed under this name. See all Cyproheptadine Hydrochloride NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Cyproheptadine Hydrochloride NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Cyproheptadine Hydrochloride	Cyproheptadine hydrochloride 2 mg/1	TabletOral	PANGEA PHARMACEUTICALS, LLC	81279-129	81279-0129-3081279-0129-60
Cyproheptadine Hydrochloride	Cyproheptadine hydrochloride 4 mg/1	TabletOral	TRUPHARMA, LLC	52817-415	52817-0415-1052817-0415-50
Cyproheptadine Hydrochloride	Cyproheptadine hydrochloride 4 mg/1	TabletOral	REMEDYREPACK INC.	70518-4667	70518-4667-00
Cyproheptadine Hydrochloride	Cyproheptadine hydrochloride 4 mg/1	TabletOral	AvPAK	50268-201	50268-0201-15
Cyproheptadine Hydrochloride	Cyproheptadine hydrochloride 2 mg/5mL	SolutionOral	Atlantic Biologicals Corp.	17856-1185	17856-1185-0117856-1185-02
Cyproheptadine Hydrochloride	Cyproheptadine hydrochloride 2 mg/5mL	SolutionOral	QUAGEN PHARMACEUTICALS LLC	70752-185	70752-0185-12
Cyproheptadine Hydrochloride	Cyproheptadine hydrochloride 4 mg/1	TabletOral	REMEDYREPACK INC.	70518-3517	70518-3517-00
Cyproheptadine Hydrochloride	Cyproheptadine 2 mg/5mL	SolutionOral	Patrin Pharma, Inc.	39328-544	39328-0544-16
Cyproheptadine Hydrochloride	Cyproheptadine hydrochloride 4 mg/1	TabletOral	Rising Pharma Holdings, Inc.	16571-805	16571-0805-0116571-0805-10
Cyproheptadine Hydrochloride	Cyproheptadine hydrochloride 2 mg/5mL	SyrupOral	Tris Pharma Inc	27808-099	27808-0099-01

All 35 Cyproheptadine Hydrochloride NDCs

Other NDCs under ANDA 208938

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 208938
Product	Strength	Form · route	Labeler	Product NDC
Cyproheptadine Hydrochloride	Cyproheptadine hydrochloride 4 mg/1	TabletOral	A-S Medication Solutions	50090-6129
Cyproheptadine Hydrochloride	Cyproheptadine hydrochloride 4 mg/1	TabletOral	Zydus Pharmaceuticals USA Inc.	70710-1110